Inhye E. Ahn
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 58
- Chronic Lymphocytic Leukemia Research 57
-
- Lymphoma Diagnosis and Treatment 23
- Co-authors
- Adrian Wiestner (36 shared papers)Xin Tian (16 shared papers)Mohammed Farooqui (7 shared papers)Jennifer R. Brown (11 shared papers)Susan Soto (15 shared papers)Clare Sun (20 shared papers)Sarah E. M. Herman (8 shared papers)Pia Nierman (10 shared papers)
- Journals
- Blood (32 papers)Clinical Cancer Research (5 papers)Hematological Oncology (4 papers)Blood Advances (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesSouth KoreaSpain
In The Last Decade
Inhye E. Ahn
63 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 85
- Genetics 856
- Pathology and Forensic Medicine 562
- Hematology 204
- Immunology 348
- Oncology 263
Countries citing papers authored by Inhye E. Ahn
This map shows the geographic impact of Inhye E. Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inhye E. Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inhye E. Ahn more than expected).
Fields of papers citing papers by Inhye E. Ahn
This network shows the impact of papers produced by Inhye E. Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inhye E. Ahn. The network helps show where Inhye E. Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Inhye E. Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 237 | |
| 2 | 2016 | 126 | |
| 3 | 2018 | 90 | |
| 4 | 2020 | 89 | |
| 5 | 2020 | 59 | |
| 6 | 2021 | 55 | |
| 7 | 2013 | 51 | |
| 8 | 2021 | 42 | |
| 9 | 2023 | 29 | |
| 10 | 2021 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2017 | 21 | |
| 13 | 2017 | 20 | |
| 14 | 2010 | 19 | |
| 15 | 2013 | 19 | |
| 16 | 2022 | 18 | |
| 17 | 2020 | 18 | |
| 18 | 2024 | 17 | |
| 19 | 2014 | 16 | |
| 20 | 2024 | 14 |
About Inhye E. Ahn
Inhye E. Ahn is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Oncology and Hematology, having authored 72 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (57 papers), Lymphoma Diagnosis and Treatment (23 papers), Immunodeficiency and Autoimmune Disorders (17 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Advanced Breast Cancer Therapies (5 papers), CAR-T cell therapy research (5 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Genetics (856 citations), Pathology and Forensic Medicine (562 citations), Hematology (204 citations), Immunology (348 citations) and Oncology (263 citations). Inhye E. Ahn has collaborated with scholars based in United States, South Korea and Spain. Frequent co-authors include Adrian Wiestner, Xin Tian, Mohammed Farooqui, Jennifer R. Brown, Susan Soto, Clare Sun, Sarah E. M. Herman, Pia Nierman, Jennifer Lotter and Juan Gea‐Banacloche. Their work appears in journals such as Blood, Clinical Cancer Research, Hematological Oncology, Blood Advances and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.